ANIXA BIOSCIENCES
Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against ฮฑ-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company's diagnostic portfolio consists of Cchekโข, a liquid biopsy technology for early detection of solid tumors based on the body's immune response to the presence of a malignancy. Anixa continually examines emerging technologies in complementary fields for further development and commercialization.
ANIXA BIOSCIENCES
Industry:
Biotechnology Finance Market Research Pharmaceutical Therapeutics
Founded:
1982-01-01
Address:
Melville, New York, United States
Country:
United States
Website Url:
http://www.anixa.com
Total Employee:
1+
Status:
Active
Contact:
6315495974
Total Funding:
34.27 M USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
PBS-Bio
PBS-Bio develops cancer treatment technologies for pre-clinical research to pharmaceutical clients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Anixa Biosciences
National Cancer Institute
National Cancer Institute investment in Grant - Anixa Biosciences
Key Employee Changes
Official Site Inspections
http://www.anixa.com Semrush global rank: 7.99 M Semrush visits lastest month: 666
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Anixa Biosciences"
Anixa Biosciences, Inc. (ANIX)
Anixa is focused on the treatment and prevention of cancer. Anixa Biosciences, Inc. is developing therapies and vaccines that are focused on critical unmet needs in oncology. Anixaโs programs โฆSee details»
Overview :: Anixa Biosciences, Inc. (ANIX)
Anixa's therapeutics portfolio consists of a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. Anixaโs โฆSee details»
Investors :: Anixa Biosciences, Inc. (ANIX)
Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program โฆSee details»
Profile - Anixa Biosciences, Inc. (ANIX)
Address: 3150 Almaden Expressway. Suite 250 San Jose, CA 95118 . Telephone: 408-708-9808. Email: [email protected]See details»
Anixa Biosciences - Crunchbase Company Profile & Funding
Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine โฆSee details»
Anixa Biosciences, Inc. (ANIX) - Yahoo Finance
See the company profile for Anixa Biosciences, Inc. (ANIX) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Anixa Biosciences, Inc. (ANIX) Company Profile & Overview - Stock โฆ
Anixa Biosciences, Inc., a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio consists of an ovarian cancer immunotherapy โฆSee details»
ANIXA BIOSCIENCES, INC. - AnnualReports.com
Anixa Biosciences, Inc. is a biotechnology company focused on using the bodyโs immune system to diagnose, treat and prevent cancer. We were incorporated on November 5, 1982 under the โฆSee details»
Company Anixa Biosciences, Inc. - MarketScreener.com
Jul 31, 2016 Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T โฆSee details»
Anixa Biosciences - Overview, News & Similar companies - ZoomInfo
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial Novel and proprietary CAR-T approach holds potential to be first effective CAR-T therapy for โฆSee details»
Management Team - Anixa Biosciences, Inc. (ANIX)
Mr. Catelani is a seasoned executive with over 30 years of finance and operations management experience. He currently serves as President, Chief Operation Officer & Chief Financial Officer โฆSee details»
Anixa Biosciences Inc Company Profile - Overview - GlobalData
Anixa Biosciences Inc (Anixa) is a biotechnology company. The company develops and acquires patented technologies in the areas such as cancer diagnostics, encrypted communications โฆSee details»
Anixa Biosciences Inc, CY71:DUS profile - FT.com - Financial Times
Nov 29, 2024 Year on year Anixa Biosciences Inc grew revenues -- from 0.00 to 210.00k while net income improved from a loss of 13.60m to a smaller loss of 9.81m. View all financials. โฆSee details»
Anixa Biosciences, Inc. (ANIX) - Stock Analysis
6 days ago About ANIX. Anixa Biosciences, Inc., a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio consists of an โฆSee details»
Board of Directors :: Anixa Biosciences, Inc. (ANIX)
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10. Read More... Nov 22, 2024. Anixa Biosciences Board of Directors Approves โฆSee details»
Corporate Presentation :: Anixa Biosciences, Inc. (ANIX)
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10. Read More... Nov 22, 2024. Anixa Biosciences Board of Directors Approves โฆSee details»
Press Releases :: Anixa Biosciences, Inc. (ANIX)
Sep 18, 2024 OCRA is the leading organization in the world fighting ovarian cancer from all fronts while supporting women and their families. ... Anixa's therapeutic portfolio consists of an โฆSee details»
Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History ...
Anixa Biosciences, Inc., a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio consists of an ovarian cancer immunotherapy โฆSee details»
Anixa In The News :: Anixa Biosciences, Inc. (ANIX)
Big Biz Show CEO Interview | Amit Kumar, Anixa Biosciences. Big Biz Show. November 13, 2024. Cleveland Clinic making progress in preventative breast cancer vaccine. News 5 Cleveland. โฆSee details»